Co-Authors
This is a "connection" page, showing publications co-authored by Lianguo Ruan and Huaxin Shi.
Connection Strength
0.118
-
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial. Phytomedicine. 2021 Oct; 91:153671.
Score: 0.060
-
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China. J Ethnopharmacol. 2021 Sep 15; 277:113888.
Score: 0.058